Publication
Global Asset Management Review: Issue 4
Welcome to the third issue of Global Asset Management Review.
Life Sciences Global Guide
Canada | Publication | October 2023
Norton Rose Fulbright lawyers Kristin Wall, Randy Sutton, Veronique Barry, Christopher Guerreiro and Sarah Pennington contributed the Canada chapters to the Practical Law Life Sciences Global Guide on commercialization and regulation. The Guide is published in a Q&A format by Thomson Reuters, which is a leading global platform for trusted, up-to-date legal know how across all major practice areas.
Life Sciences Commercialisation in Canada: Overview
The Q&A Guide to life sciences commercialisation in Canada provides an overview of Canada’s life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.
Life Sciences Regulation in Canada: Overview
The Q&A guide to life sciences regulation in Canada reviews the main legislation governing pharmaceuticals in Canada. The guide provides an overview of key practical issues, including clinical trials, manufacturing, marketing, abridged procedures, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, and natural health products.
Partner, Lawyer, Trademark Agent
Email
kristin.wall@nortonrosefulbright.com
Global Co-Head of Life Sciences and Healthcare; Partner
Email
randy.sutton@nortonrosefulbright.com
Senior Lawyer, Litigation
Email
christopher.guerreiro@nortonrosefulbright.com
Associate
Email
sarah.pennington@nortonrosefulbright.com
Recent publications
Publication
European Parliament votes to adopt Omnibus proposal amending CSRD and CS3D
On 13 November 2025, the European Parliament adopted (subject to certain amendments) the substantive Omnibus Directive which was proposed by the European Commission on 26 February 2025 (see our previous briefing here). On 16 December 2025, the European Parliament adopted further proposed amendments.
Subscribe and stay up to date with the latest legal news, information and events . . .